Quantilex Plus XL Tablets for Dogs

Страна: Велика Британія

мова: англійська

Джерело: VMD (Veterinary Medicines Directorate)

Активний інгредієнт:

Febantel, Praziquantel, Pyrantel Embonate

Доступна з:

Chanelle Pharmaceuticals Manufacturing Ltd

Код атс:

QP52AA51

ІПН (Міжнародна Ім'я):

Febantel, Praziquantel, Pyrantel Embonate

Фармацевтична форма:

Tablet

Тип рецепту:

NFA-VPS - Non-Food Animal – Veterinarian, Pharmacist, Suitably Qualified Person

Терапевтична група:

Dogs

Терапевтична области:

Anthelmintic anticestodal

Статус Авторизація:

Authorized

Дата Авторизація:

2015-01-29

Характеристики продукта

Revised: December 2023
AN: 03295/2022
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Quantilex Plus XL Tablets for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Praziquantel
175 mg
Pyrantel Embonate
504 mg (equivalent to 175 mg pyrantel)
Febantel
525 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
A yellow-coloured oblong tablet with a breakline on both sides.
The tablets can be divided into equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by nematodes and cestodes of the
following
species
NEMATODES:
ASCARIDS: _Toxocara canis_, _Toxascaris leonina_ (adult and late
immature forms).
HOOKWORMS: _Uncinaria stenocephala_, _Ancylostoma caninum_ (adults).
WHIPWORMS: _Trichuris vulpis_ (adults).
CESTODES:
TAPEWORMS: _Echinococcus_ species _(E. granulosus, E. multilocularis),
Taenia_
species
_(T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum_
(adult and
immature forms).
Revised: December 2023
AN: 03295/2022
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
Do not use during the 1st and 2nd trimester of pregnancy (see section
4.7)
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Fleas serve as intermediate hosts for one common type of tapeworm –
_Dipylidium caninum_. Tapeworm infestation is certain to reoccur
unless control
of intermediate hosts such as fleas, mice, etc. is undertaken.
Parasite resistance to any particular class of anthelmintic may
develop
following frequent, repeated use of an anthelmintic of that class.
To minimise the risk of reinfestation and new infestation, excreta
should be
collected and properly disposed of for 24 hours following treatment.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by th